Outcomes in squamous cell carcinoma with advanced neck disease
- PMID: 17959009
- PMCID: PMC2121299
- DOI: 10.1308/003588407X205314
Outcomes in squamous cell carcinoma with advanced neck disease
Abstract
Introduction: Treatment of advanced neck disease (N2c/N3) in head and neck squamous cell carcinoma is contentious. The aim of this study was to review the survival outcome following surgical excision of neck disease and the complications of this surgery.
Patients and methods: A retrospective review of the case notes of 39 patients treated at the Oxford Radcliffe Infirmary Head and Neck Unit with squamous cell carcinoma and advanced neck metastases confirmed as either pN2c or pN3 on histological examination was performed. Patients were treated with surgery and, in some cases, with adjunctive postoperative radiotherapy at the centre between August 1996 and November 2004. The study sought to establish the demographics, UICC staging/pathology, method of treatment, complications, recurrence and survival. Kaplan-Meier curves were used for statistical analysis of survival. Comparisons were then made between the cohort and historical control groups.
Results: All patients were UICC stage IV disease. The 2- and 5-year overall survival in patients with resectable disease was 63% and 52%, respectively.
Discussion: Patients with advanced neck disease have traditionally been thought to have terrible prognosis and, therefore, treatment is controversial. In treating advanced head and neck cancer, there has been a recent trend away from surgery towards chemotherapy and/or radiotherapy.
Conclusions: Comparing this study group to historical controls that include chemotherapy and/or radiotherapy, the outcomes appear favourable. The use of a combination of radiotherapy and surgery is advocated; it is suggested that advanced neck disease can have an acceptable prognosis and morbidity and that local disease control may be achieved.
Figures
Similar articles
-
Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy: for some or for all?Head Neck. 1999 Oct;21(7):606-13. doi: 10.1002/(sici)1097-0347(199910)21:7<606::aid-hed4>3.0.co;2-g. Head Neck. 1999. PMID: 10487947
-
Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma.Acta Otolaryngol. 2013 Oct;133(10):1104-9. doi: 10.3109/00016489.2013.811751. Acta Otolaryngol. 2013. PMID: 24032573
-
Outcomes of head and neck squamous cell carcinoma patients with N3 neck disease treated primarily with chemoradiation versus surgical resection.Laryngoscope. 2011 Sep;121(9):1881-7. doi: 10.1002/lary.21968. Laryngoscope. 2011. PMID: 21997727
-
Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy.Cancer. 2005 Oct 1;104(7):1408-17. doi: 10.1002/cncr.21340. Cancer. 2005. PMID: 16130134
-
Controlling advanced neck disease: efficacy of neck dissection and radiotherapy.Laryngoscope. 2000 Jul;110(7):1124-7. doi: 10.1097/00005537-200007000-00010. Laryngoscope. 2000. PMID: 10892681 Review.
Cited by
-
Higher Expression of SPP1 Predicts Poorer Survival Outcomes in Head and Neck Cancer.J Immunol Res. 2021 Dec 23;2021:8569575. doi: 10.1155/2021/8569575. eCollection 2021. J Immunol Res. 2021. PMID: 34977258 Free PMC article.
-
Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry.Clin Cancer Res. 2023 Mar 1;29(5):910-920. doi: 10.1158/1078-0432.CCR-22-2258. Clin Cancer Res. 2023. PMID: 36508165 Free PMC article.
-
Common skin cancers and their association with other non-cutaneous primary malignancies: a review of the literature.Med Oncol. 2024 May 17;41(6):157. doi: 10.1007/s12032-024-02385-7. Med Oncol. 2024. PMID: 38758457 Review.
-
Tumor Cell Stemness and Stromal Cell Features Contribute to Oral Cancer Outcome Disparity in Black Americans.Cancers (Basel). 2024 Jul 31;16(15):2730. doi: 10.3390/cancers16152730. Cancers (Basel). 2024. PMID: 39123459 Free PMC article.
-
The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer.Am J Case Rep. 2018 Oct 18;19:1241-1244. doi: 10.12659/AJCR.910224. Am J Case Rep. 2018. PMID: 30333474 Free PMC article.
References
-
- Hicks WL, Kollmorgen DR, Kuriakose MA, Orner J, Bakamijan VY, Winston J, et al. Patterns of nodal metastasis and surgical management of the neck in supra-glottic laryngeal carcinoma. Otolaryngol Head Neck Surg. 1999;121:57–61. - PubMed
-
- Shah JP, Shara AR, Medina JE. Cervical lymph node metastasis. Curr Prob Surg. 1993;20:275–335. - PubMed
-
- Feind CR, Cole RM. Contralateral spread of head and neck cancer. Am J Surg. 1969;118:660–5. - PubMed
-
- McGuirt F, McCabe BF. Bilateral radical neck dissections. Arch Otolaryngol. 1980;106:427–9. - PubMed
-
- British Association of Otolaryngologists and Head and Neck Surgeons. Effective Head and Neck Cancer Management – Consensus Documents 1998 and 2002.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical